BGT
BIO-GENE TECHNOLOGY LTD
$0.0160
▼ -5.88%
Market cap
$7M
Turnover
$10,489
Last price
$0.0160
Day change
-5.88%
Announcements
6
Range, past year
Open 0.034 · Low 0.016 · Now 0.016 · High 0.061
Open BGT in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
BGT momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
24/100
Wyckoff phase
Accumulation7d
Trend stage
Neutral
1 Day
-5.9%
1 Week
-11.1%
1 Month
-15.8%
1 Year
-55.6%
RSI
34
Avg daily range
10.4%
BIO-GENE TECHNOLOGY LTD scores 24 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 7 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -30.4%
- High volatility (ATR 10.4%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
BGT announcements
Recent price-sensitive releases.
- 2026-08-28 Appendix 4E and 2026 Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-31 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-05-26 Results of Placement
- 2026-05-22 Trading Halt
- 2026-04-27 Quarterly Activities/Appendix 4C Cash Flow Report
More Materials stocks
Most traded in the same sector.